Medicare Officially Limits Aduhelm’s Coverage To Patients In Clinical Trials
Ever since Medicare proposed to severely limit coverage of the controversial Alzheimer’s drug Aduhelm, the agency has been inundated with passionate pleas. Groups representing patients… Read More »Medicare Officially Limits Aduhelm’s Coverage To Patients In Clinical Trials